LifeMD, Inc. ( LFMD) Q1 2026 Earnings Call May 6, 2026 4:30 PM EDT Good afternoon. Thank you for joining us today to discuss LifeMD's results for the first quarter ended March 31, 2026.

Micron is deeply undervalued despite YoY revenue and net income margin growth driven by structural AI demand. Find out why MU ...

Thursday, May 7, 2026 at 10 a.m. ET Chief Executive Officer — John Joseph Abularrage Co-Chief Executive Officer — Sean A. Windeatt Co-Chief Executive Officer — Jean-Pierre Aubin Chief Financial ...

AMA-driven bipartisan legislation to overhaul MIPS introduced in the House of Representatives Since its creation following the enactment of the Medicare Access and CHIP Reauthorization Act (MACRA) of ...

Primary results from CALIBRATE, the Phase 3 registrational clinical trial of encaleret, will be shared in an oral presentation at the 2026 European Congress of Endocrinology (ECE) on May 12, 2026 at ...

Delivered Year-over-Year Revenue Growth and Increases Expectation for Full Year FY26 Revenue and Free Cash Flow*Net Income was $26 million. Adjusted EBITDA* was $126 million, an increase of 41% ...